The core-binding factor leukemias: lessons learned from murine models - PubMed (original) (raw)
Review
The core-binding factor leukemias: lessons learned from murine models
James R Downing. Curr Opin Genet Dev. 2003 Feb.
Abstract
The recent development of murine models of core-binding factor leukemias has provided important insights into the underlying molecular pathology of this common subtype of acute myeloid leukemia. Evidence from these models supports the idea that acute myeloid leukemia 1/core-binding factor beta-subunit (AML1/CBFbeta) has a critical role in the control of the self-renewal capacity of hematopoietic stem cells and their progeny. Moreover, the accumulated data demonstrate that the expression of translocation-encoded AML1 or CBFbeta fusion proteins are insufficient by themselves to induce a full leukemic phenotype. The models that have been developed should prove to be of value for defining the range of mutations that can cooperate with AML1/CBFbeta fusion proteins, and for assessing novel therapies targeted toward the pathways that are altered by the expression of these fusion proteins.
Similar articles
- Alterations of the AML1 transcription factor in human leukemia.
Downing JR, Higuchi M, Lenny N, Yeoh AE. Downing JR, et al. Semin Cell Dev Biol. 2000 Oct;11(5):347-60. doi: 10.1006/scdb.2000.0183. Semin Cell Dev Biol. 2000. PMID: 11105899 Review. - The role of the AML1 transcription factor in leukemogenesis.
Lorsbach RB, Downing JR. Lorsbach RB, et al. Int J Hematol. 2001 Oct;74(3):258-65. doi: 10.1007/BF02982058. Int J Hematol. 2001. PMID: 11721960 Review. - The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F, Pisegna S, Diverio D. Lo Coco F, et al. Haematologica. 1997 May-Jun;82(3):364-70. Haematologica. 1997. PMID: 9234595 Review. - Leukemogenesis by CBF oncoproteins.
Friedman AD. Friedman AD. Leukemia. 1999 Dec;13(12):1932-42. doi: 10.1038/sj.leu.2401590. Leukemia. 1999. PMID: 10602413 Review.
Cited by
- In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesis.
Lara-Astiaso D, Goñi-Salaverri A, Mendieta-Esteban J, Narayan N, Del Valle C, Gross T, Giotopoulos G, Beinortas T, Navarro-Alonso M, Aguado-Alvaro LP, Zazpe J, Marchese F, Torrea N, Calvo IA, Lopez CK, Alignani D, Lopez A, Saez B, Taylor-King JP, Prosper F, Fortelny N, Huntly BJP. Lara-Astiaso D, et al. Nat Genet. 2023 Sep;55(9):1542-1554. doi: 10.1038/s41588-023-01471-2. Epub 2023 Aug 14. Nat Genet. 2023. PMID: 37580596 Free PMC article. - Childhood hematopoietic stem cells constitute the permissive window for RUNX1-ETO leukemogenesis.
Abdallah MG, Teoh VSI, Dutta B, Yokomizo T, Osato M. Abdallah MG, et al. Int J Hematol. 2023 Jun;117(6):830-838. doi: 10.1007/s12185-023-03605-y. Epub 2023 May 2. Int J Hematol. 2023. PMID: 37129801 Review. - PPP1R7 Is a Novel Translocation Partner of CBFB via t(2;16)(q37;q22) in Acute Myeloid Leukemia.
Wang L, Wang W, Beird HC, Cheng X, Fang H, Tang G, Toruner GA, Yin CC, You MJ, Issa GC, Borthakur G, Peng G, Khoury JD, Medeiros LJ, Tang Z. Wang L, et al. Genes (Basel). 2022 Jul 29;13(8):1367. doi: 10.3390/genes13081367. Genes (Basel). 2022. PMID: 36011278 Free PMC article. - Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectives.
Bouligny IM, Maher KR, Grant S. Bouligny IM, et al. Blood Rev. 2023 Jan;57:100996. doi: 10.1016/j.blre.2022.100996. Epub 2022 Aug 2. Blood Rev. 2023. PMID: 35989139 Free PMC article. Review. - Murine Models of Acute Myeloid Leukemia.
Kurtz KJ, Conneely SE, O'Keefe M, Wohlan K, Rau RE. Kurtz KJ, et al. Front Oncol. 2022 Jun 8;12:854973. doi: 10.3389/fonc.2022.854973. eCollection 2022. Front Oncol. 2022. PMID: 35756660 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases